The Effect of Grape Seed Extract on Blood Pressure in People With Pre-Hypertension (GSE)

Illinois Institute of Technology

Status: Completed

Conditions: Hypertension

Treatments: Dietary Supplement: grape seed extract placebo; Dietary Supplement: grape seed extract

Study type: Interventional

Funder types: Industry

Identifiers

NCT00979732

GSE 2009-050

Details and patient eligibility

About

In this research study, the investigators are interested in learning how extracts from grape seeds can help those individuals with high blood pressure. The investigators also hope to learn how grape seed extract effects your blood and cell functions.

The grape seed extract the investigators will use in the study will be provided either in a beverage or a capsule form and is currently available on the market. This study is also using a placebo; therefore the treatment subjects receive may or may not contain the grape seed extract.

The purpose of this study is to determine if the grape seed extract (GSE) will lower blood pressure in people with slightly high blood pressure (Pre-Hypertension).

Full description

Elevated blood pressure, or hypertension, is a major risk factor for heart disease and stroke. Systolic and diastolic blood pressures meeting criteria for "pre-hypertension" double the absolute risk of stroke and ischemic heart disease over an extended age range from the 4th to the 8th decade of life. Lifestyle, particularly the diet, is critical in the prevention and management of hypertension. Polyphenolic compounds from various plant foods can promote blood pressure regulation and vascular health through protection of the endothelium from oxidant and or inflammatory stress and or stimulation of smooth muscle relaxation.

We will use a purified grape seed extract (GSE) in the proposed trial. This extract has been granted Generally Recognized as Safe (GRAS) status by Food and drug administration (GRAS Notice # GRN 000125, dated 08/18/2003, FDA, USA). Furthermore, GSE for use in the present trial has been used in previous human clinical trails and shown potent vasodilator properties in vitro and blood pressure lowering in metabolic syndrome patients. The proposed trial aims to verify the blood pressure lowering effect of GSE in an 'at risk' population for hypertension and to explore the extent to which other pathways of chronic disease may be modulated by GSE consumption.

Given this, the objectives of this study are as follows:

1. The primary objective of the proposed study is to demonstrate the effectiveness of GSE to lower blood pressure in pre-hypertensive individuals.
2. Secondary objectives will investigate the role of GSE to improve inflammatory- and oxidative stress- status, as well as its effect on endothelium function.

Enrollment: 33 patients

Sex: All

Ages: 25 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• male and female

• pre-hypertensive

  • systolic blood pressure (mmHg) 120 - 139 or
  • diastolic blood pressure (mmHg) 80 -89

• no clinical evidence of cardiovascular, respiratory, renal, gastrointestinal or hepatic disease

Exclusion criteria

• pregnant and or lactating
• taking over the counter antioxidant supplements
• taking prescription medications that may interfere with study procedures or endpoints
• unusual dietary habits
• actively trying to lose or gain weight
• addicted to drugs and/or alcohol
• medically documented psychiatric or neurological disturbances
• smoker (past smoker may be allowed if cessation is > 2 years)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

33 participants in 2 patient groups, including a placebo group

GSE beverage active

Active Comparator group

Description:

grape seed extract beverage 150 mg/BID

Treatment:

Dietary Supplement: grape seed extract

GSE beverage placebo

Placebo Comparator group

Description:

grape seed extract placebo beverage 150 mg/BID

Treatment:

Dietary Supplement: grape seed extract placebo